A single amino acid substitution in a WW-like domain of diverse members of the PDGF receptor subfamily of tyrosine kinases causes constitutive receptor activation

EMBO Journal

Volumn 17, Issue 23, 1998, Pages 6912-6923

  Irusta, Pablo M ^a   DiMaio, Daniel ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

c kit; Oncogene; PDGF receptor; Tyrosine kinase; WW domain

Indexed keywords

ALANINE; CYTOPLASM PROTEIN; INTERLEUKIN 3; LIGAND; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONSENSUS SEQUENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALIA; MURINAE;

EID: 0032401747     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.23.6912     Document Type: Article

References (42)

1. Bargmann, C.I., Hung, M.C. and Weinberg, R.A. (1986) The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature, 319, 226-230.
2. Baxter, R.M., Secrist, J.P., Vaillancourt, R.R. and Kazlauskas, A. (1998) Full activation of the platelet-derived growth factor β-receptor kinase involves multiple events. J. Biol. Chem., 273, 17050-17055.
3. Cahir McFarland, E.D. and Thomas, M.L. (1995) CD45 protein-tyrosine phosphatase associates with the WW domain-containing protein, CD45AP, through the transmembrane region. J. Biol. Chem., 270, 28103-28107.
4. Carroll, M., Tomasson, M.H., Barker, G.F., Golub, T.R. and Gilliland, D.G. (1996) The TEL/platelet-derived growth factor β receptor (PDGF β R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF β R kinase-dependent signaling pathways. Proc. Natl Acad. Sci. USA, 93, 14845-14850.
5. Chen, H.E., Chang, S., Trub, T. and Neel, B.G. (1996) Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol. Cell. Biol., 16, 3685-3697.
6. Chi, K.D., McPhee, R.A., Wagner, A.S., Dietz, J.J., Pantazis, P. and Goustin, A.S. (1997) Integration of proviral DNA into the PDGF β-receptor gene in HTLV-1-infected T-cells results in a novel tyrosine kinase product with transforming activity. Oncogene, 15, 1051-1057.
7. Drummond-Barbosa, D., Vaillancourt, R.R., Kazlauskas, A. and DiMaio, D. (1995) Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling. Mol. Cell. Biol., 15, 2570-2581.
8. Einbond, A. and Sudol, M. (1996) Towards prediction of cognate complexes between the WW domain and proline-rich ligands. FEBS Lett., 384, 1-8.
9. Escobedo, J.A., Barr, P.J. and Williams, L.T. (1988) Role of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet-derived growth factor receptor. Mol. Cell. Biol., 8, 5126-5131.
10. Frangioni, J.V. and Neel, B.G. (1993) Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal. Biochem., 210, 179-187.
11. Golub, T.R., Barker, G.F. Lovett, M. and Gilliland, D.G. (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell, 77, 307-316.
12. Hansen, K., Johnell, M., Siegbahn, A., Rorsman, C., Engström, U., Wernstedt, C., Heldin, C.-H. and Rönnstrand, L. (1996) Mutation of a Src phosphorylation site in the PDGF β-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis. EMBO J., 15, 5299-5313.
13. Heldin, C.-H. (1992) Structural and functional studies on platelet-derived growth factor. EMBO J., 11, 4251-4259.
14. Hirota, S. et al. (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science, 279, 577-580.
15. Kaelin, W.G., Jr et al. (1992) Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell, 70, 351-364.
16. Kanakura, Y. et al. (1994) Activating mutations of the c-Kit proto-oncogene in a human mast cell leukemia cell line. Leukemia, 8, S18-S22.
17. Kelly, J.D., Haldeman, B.A., Grant, F.J., Murray, M.J., Seifert, R.A., Bowen-Pope, D.F. Cooper, J.A. and Kazlauskas, A. (1991) Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation. J. Biol. Chem., 266, 8987-8992.
18. Kitayama, H. et al. (1995) Constitutively activating mutations of c-Kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood, 85, 790-798.
19. Kovalenko, M., Gazit, A., Böhmer, A., Rorsman, C., Rönnstrand, L., Heldin, C.-H., Waltenberger, J., Bohmer, F.-D. and Levitzki, A. (1994) Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res., 54, 6106-6114.
20. Kozlowski, M. Larose, L., Lee, F., Le, D.M., Rottapel, R. and Siminovitch, K.A. (1998) SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain. Mol. Cell. Biol., 18, 2089-2099.
21. Lai, C.C., Henningson, C. and DiMaio, D. (1998) Bovine papillomavirus E5 protein induces oligomerization and trans-phosphorylation of the platelet-derived growth factor receptor. Proc. Natl Acad. Sci. USA, in press.
22. Lorenz, U., Bergemann, A.D., Steinberg, H.N., Flanagan, J.G., Li, X., Galli, S.J. and Neel, B.G. (1996) Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1. J. Exp. Med., 184, 1111-1126.
23. Mori, S., Rönnstrand, L., Yokote, K., Engström, Å., Courtneidge, S.A., Claesson-Welsh, L. and Heldin, C.-H. (1993) Identification of two juxtamembrane autophosphorylation sites in the PDGF β-receptor; involvement in the interaction with Src family tyrosine kinases. EMBO J., 12, 2257-2264.
24. Palacios, R. and Steinmetz, M. (1985) IL-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration and generate B lymphocytes in vivo. Cell, 41, 727-734.
25. Paulson, R.F., Vesely, S., Siminovitch, K.A. and Bernstein, A. (1996) Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nature Genet., 13, 309-315.
26. Pear, W.S., Nolan, G.P., Scott, M.L. and Baltimore, D. (1993) Production of high-liter helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. USA, 90, 8392-8396.
27. Petti, L. and DiMaio, D. (1994) Specific interaction between the bovine papillomavirus E5 transforming protein and the β receptor for platelet-derived growth factor in stably transformed and acutely transfected cells. J. Virol., 68, 3582-3592.
28. Petti, L.M., Reddy, V., Smith, S.O. and DiMaio, D. (1997) Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein. J. Virol., 71, 7318-7327.
29. neu. Oncogene, 16, 843-851.
30. Piao, X., Paulson, R., van der Geer, P. Pawson, T. and Bernstein, A. (1996) Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. Proc. Natl Acad. Sci. USA, 93, 14665-14669.
31. Pirozzi, G., McConnell, S.J., Uveges, A.J., Carter, J.M., Sparks, A.B., Kay, B.K. and Fowlkes, D.M. (1997) Identification of novel human WW domain-containing proteins by cloning of ligand targets. J. Biol. Chem., 272, 14611-14616.
32. Ross, T.S., Bernard, O.A., Berger, R. and Gilliland, D.G. (1998) Fusion of Huntington interacting protein 1 to platelet-derived growth factor β receptor (PDGFβR) in chronic myelomonocytic leukemia with t(5;7) (q33; q11.2). Blood, 91, 4419-4426.
33. Roussel, M., Downing, J., Rettenmier, C.W. and Sherr, C.J. (1988) A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential. Cell. 55, 979-988.
34. Santoro, M. et al. (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science, 267, 381-383.
35. Smith, S.O., Smith, C.S. and Bormann, B.J. (1996) Strong hydrogen bonding interactions involving a buried glutamic acid in the transmembrane sequence of the neu/erB-2 receptor. Nature Struct. Biol., 3, 252-258.
36. Songyang, Z. et al. (1995) Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature, 373, 536-539.
37. Sudol, M. (1996) Structure and function of the WW domain. Prog. Biophys. Mol. Biol., 65, 113-132.
38. Ullrich, A. and Schlessinger, J. (1990) Signal transduction by receptors with tyrosine kinase activity. Cell, 61, 203-212.
39. Valius, M. and Kazlauskas, A. (1993) Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell, 73, 321-334.
40. Valius, M., Secrist, J.P. and Kazlauskas, A. (1995) The GTPase-activating protein of Ras suppresses platelet-derived growth factor β receptor signaling by silencing phospholipase C-γ 1. Mol. Cell. Biol., 15, 3058-3071.
41. Weiner, D.B., Liu, J., Cohen, J.A., Williams, W.V. und Greene, M.I. (1989) A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature, 339, 230-231.
42. Yarden, Y. et al. (1986) Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature, 323, 226-232.